Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance
- PMID: 24512497
- DOI: 10.1210/jc.2013-4133
Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance
Abstract
Context: The association between nonalcoholic fatty liver disease (NAFLD) and subclinical atherosclerosis in type 2 diabetes is controversial.
Objective: The objective of the study was to investigate the participation of insulin resistance in the association of NAFLD and the carotid atherosclerotic burden in a large cohort of patients with type 2 diabetes.
Design, setting, and patients: This was an observational study performed in 4437 consecutively enrolled patients with type 2 diabetes.
Main outcomes measures: Hepatic steatosis and mean carotid intima-media thickness (C-IMT) were measured using ultrasonography. Insulin resistance was assessed using the short insulin tolerance test.
Results: The prevalence of NAFLD was 72.7% in the whole study population. Among subjects with NAFLD, 23.2% were not insulin resistant. There were significant differences in C-IMT and the frequency of carotid atherosclerosis between groups classified by insulin resistance within the same NAFLD strata. C-IMT was highest in subjects with both NAFLD and insulin resistance [0.844 ± 0.004 (mean ± SE) mm vs 0.786 ± 0.008, 0.821 ± 0.007, and 0.807 ± 0.006 mm, P for trend <.001, respectively, in insulin sensitive subjects without NAFLD, insulin resistant subjects without NAFLD, and insulin sensitive subjects with NAFLD]. These differences remained after adjusting for potential confounders. However, C-IMT in subjects having only NAFLD or insulin resistance was not higher than that in those with neither NAFLD nor insulin resistance.
Conclusions: NAFLD is very common in subjects with type 2 diabetes, but NAFLD not accompanied by insulin resistance is not associated with a carotid atherosclerotic burden. However, having both NAFLD and insulin resistance seemed to be an independent predictor of increased C-IMT.
Similar articles
-
[Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].Korean J Hepatol. 2008 Mar;14(1):77-88. doi: 10.3350/kjhep.2008.14.1.77. Korean J Hepatol. 2008. PMID: 18367860 Korean.
-
Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome.Atherosclerosis. 2009 Jun;204(2):521-5. doi: 10.1016/j.atherosclerosis.2008.09.012. Epub 2008 Sep 19. Atherosclerosis. 2009. PMID: 18947828
-
The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.Endocr J. 2013;60(12):1295-301. doi: 10.1507/endocrj.ej13-0269. Epub 2013 Sep 18. Endocr J. 2013. PMID: 24047563
-
Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis.Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1237-48. doi: 10.1097/MEG.0000000000000429. Eur J Gastroenterol Hepatol. 2015. PMID: 26193052 Review.
-
The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis.Clin Liver Dis. 2012 Aug;16(3):599-613. doi: 10.1016/j.cld.2012.05.008. Epub 2012 Jul 3. Clin Liver Dis. 2012. PMID: 22824483 Review.
Cited by
-
Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus.Diabetes Metab J. 2023 Mar;47(2):232-241. doi: 10.4093/dmj.2021.0355. Epub 2023 Jan 19. Diabetes Metab J. 2023. PMID: 36653888 Free PMC article.
-
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease.Clin Mol Hepatol. 2020 Oct;26(4):430-443. doi: 10.3350/cmh.2020.0137. Epub 2020 Aug 14. Clin Mol Hepatol. 2020. PMID: 32791578 Free PMC article. Review.
-
Differences in complication patterns in subgroups of type 2 diabetes according to insulin resistance and beta-cell function.Sci Rep. 2022 Jun 7;12(1):9384. doi: 10.1038/s41598-022-13084-6. Sci Rep. 2022. PMID: 35672344 Free PMC article.
-
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.Diabetes Metab J. 2020 Jun;44(3):382-401. doi: 10.4093/dmj.2020.0010. Epub 2020 May 11. Diabetes Metab J. 2020. PMID: 32431115 Free PMC article. Review.
-
Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota.Nutrients. 2021 Dec 27;14(1):103. doi: 10.3390/nu14010103. Nutrients. 2021. PMID: 35010976 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical